EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Deprescribing trials need a rationale-first framework before choosing trial design

Lorenz Roger Van der Linden

The Lancet Healthy Longevity · 2026-08 · 7 (8) · 100892

DOI: 10.1016/j.lanhl.2026.100892 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Lancet Healthy Longevity, 2026-08. Verfasst von Lorenz Roger Van der Linden. Beteiligte Einrichtung: Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 300…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In their Comment, published in The Lancet Healthy Longevity, Catherine S Hwang and colleagues provide a rigorous argument for the use of non-inferiority designs in medication deprescribing research.1 Their formulation of the null hypothesis, implications of attrition bias, and dual-analysis requirement for non-inferiority inference are important methodological contributions. Non-inferiority designs shift the burden of proof appropriately when treatment continuation is the default. Three further considerations merit attention.

Autor:innen und Institutionen

  • Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Electronic address: lorenz.vanderlinden@uzleuven.be.

Zitieren

APA

Van der Linden, L. R. (2026). Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity, 7(8), 100892. https://doi.org/10.1016/j.lanhl.2026.100892

Vancouver

Van der Linden LR. Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity. 2026;7(8):100892. doi:10.1016/j.lanhl.2026.100892

BibTeX
@article{VanderLinden2026,
  author = {Van der Linden, Lorenz Roger},
  title = {Deprescribing trials need a rationale-first framework before choosing trial design},
  journal = {The Lancet Healthy Longevity},
  year = {2026},
  volume = {7},
  number = {8},
  pages = {100892},
  doi = {10.1016/j.lanhl.2026.100892}
}
Kostenlos starten →